Trials / Recruiting
RecruitingNCT05697575
Non-immunogenic Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice
Non-interventional Observational Study to Evaluate the Efficacy and Safety of Non-immune Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 336 (estimated)
- Sponsor
- National Society for Neurosonology and Cerebral Circulation · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The study will collect data from aged 18 to 85 years with a diagnosis of acute stroke, who received thrombolytic treatment with a new agent, nonimmunogenic staphylokinase. Outcomes will be checked for safety and compared to the results of treatment with the other thrombolytic drug, alteplase.
Conditions
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2030-02-01
- Completion
- 2030-05-10
- First posted
- 2023-01-26
- Last updated
- 2026-04-13
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT05697575. Inclusion in this directory is not an endorsement.